Official registry condition

Chronic Renal Failure peptide trials

10 selected ClinicalTrials.gov records carrying the official condition label Chronic Renal Failure. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

10 selected records.

Connected peptides

1 profiles.

Registry update years

2012–2019 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 16 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Chronic Renal Failure unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00097747

PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00228436

PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00228449

PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.

PeptideScanner change date
November 16, 2026
Cited source date
December 21, 2012
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →